Edit
Precision Therapeutics
http://www.precisiontherapeutics.com/Last activity: 18.06.2010
Active - Reference to Predictive Oncology Inc.
Location: United States, Pennsylvania, Pittsburgh
Total raised: $35M
Investors 1
| Date | Name | Website |
| - | Horizon Te... | horizontec... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.06.2010 | - | $35M | - |
Mentions in press and media 8
| Date | Title | Description |
| 18.06.2010 | Precision Therapeutics Raises $35M | Precision Therapeutics, a Pittsburgh, Pennsylvania-based life science company that develops innovative markers to help guide treatment decisions based on the biological processes of each individual’s cancer, has recently raised $35m in vent... |
| 08.06.2010 | Precision Therapeutics raises $34M for personalized chemotherapy test | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R... |
| 17.03.2008 | Life-science briefing: Monday, March 17, 2008 | TODAY’S HEADLINES: Defibrillator maker Cameron Health takes in $14M (VBLS exclusive) Miramar Labs gets $20M for “aesthetic” devices (VBLS exclusive) Nellix raises $6.5M for aneurysm grafts (VBLS exclusive) Vessel-clog remover Chestnut Medic... |
| 05.03.2008 | Precision Thera merger with “blank check” firm Oracle Healthcare collapses | (UPDATED: See below.) Another one bites the dust. The saga of Precision Therapeutics, a Pittsburgh biotech developing what struck me last August as a particularly crude type of cancer-chemotherapy diagnostic, continues apace. In a tersely w... |
| 07.02.2008 | IPO roundup: Is the window slamming on life sciences? | It’s sure starting to look that way. News that Archemix, a Cambridge, Mass., developer of aptamer-based drugs, yesterday withdrew its $72.5 million IPO follows closely on the heels of several other recent several other IPO collapses, includ... |
| 04.12.2007 | Precision Thera drops IPO, goes public via reverse merger | (UPDATE: The merger is dead.) Pittsburgh’s Precision Therapeutics, a biotech working on diagnostics designed to identify the best chemotherapy for cancer patients, appears to have dropped its planned IPO and instead went public via a revers... |
| 24.08.2007 | Life sciences briefing: Friday, Aug. 24, 2007 | (UPDATED at 11am PT on Sunday, 8/26/07: See below.) Featured companies: Clinical Data, Epidauros Biotechnologie, Precision Therapeutics, UMD, Zars Pharma UMD to close $8M for menstrual pain and osteoporosis — Cincinnati’s UMD, a developer o... |
| - | Precision Therapeutics raises $34M for personalized chemotherapy test | Precision Therapeutics Inc. has raised $34 million in equity and options to further develop a test that helps identify an individual’s best chemotherapy options, according to a filing with the Securities and Exchange Commission. The company... |